Date updated:01-07-2009
Ratigan brought in Mick Huckman, a CNBC reporter, to talk about the prospects for biopharma stocks in 2009

-
BIIB
Biogen Idec Inc - $45.41
- -0.76%
- $45.67
Takeover targets are wide ranging and include Biogen [BIIB], Amylin (AMLN), OSI Pharma [OSIP], and Vertex Pharma [VRTX], says Huckman.

-
AMLN
Amylin Pharmaceut - $12.30
- +1.91%
- $12.12
Takeover targets are wide ranging and include Biogen [BIIB], Amylin (AMLN), OSI Pharma [OSIP], and Vertex Pharma [VRTX], says Huckman.

-
OSIP
Osi Pharmaceutica - $32.93
- -1.17%
- $33.18
Takeover targets are wide ranging and include Biogen [BIIB], Amylin (AMLN), OSI Pharma [OSIP], and Vertex Pharma [VRTX], says Huckman.

-
VRTX
Vertex Pharmaceut - $39.99
- +1.96%
- $39.12
Takeover targets are wide ranging and include Biogen [BIIB], Amylin (AMLN), OSI Pharma [OSIP], and Vertex Pharma [VRTX], says Huckman.

-
GILD
Gilead Sciences - $46.58
- +0.69%
- $46.42
"You might want to keep an eye on Gilead [GILD], Onyx [ONXX], Myriad [MYGN] and Orexigen [OREX], ahead of the JP Morgan healthcare conference on Jan. 12th," adds Mike Huckman.

-
ONXX
Onyx Pharmaceutic - $26.66
- +0.23%
- $26.68
"You might want to keep an eye on Gilead [GILD], Onyx [ONXX], Myriad [MYGN] and Orexigen [OREX], ahead of the JP Morgan healthcare conference on Jan. 12th," adds Mike Huckman.

-
ONXX
Onyx Pharmaceutic - $26.66
- +0.23%
- $26.68
"You might want to keep an eye on Gilead [GILD], Onyx [ONXX], Myriad [MYGN] and Orexigen [OREX], ahead of the JP Morgan healthcare conference on Jan. 12th," adds Mike Huckman.

-
MYGN
Myriad Genetics - $22.85
- 0.00%
- $N/A
"You might want to keep an eye on Gilead [GILD], Onyx [ONXX], Myriad [MYGN] and Orexigen [OREX], ahead of the JP Morgan healthcare conference on Jan. 12th," adds Mike Huckman.
- Fast Money's Biotech Trades's Blog
- No Blogs Found
- Top Professional Portfolios
- 1. Navellier & Associ...
- 2. Fidelity Contrafund - ...
- 3. Argus Management
- 4. Charlie Munger
- 5. Calamos Advisors
- show all
- Top Do-It-Yourself Portfolios
- » Joy
- » tsamanuli Portfolio 1
- » Albo's First Portfolio
- » Fundsonly Portfolio 1
- » rk00005
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Jonas Elmerraji Posted on Nov. 10, 2009 After six straight days of gains, the markets are taking a breather today, which gives us the chance to focus our attention b...
By Roberto Pedone Posted on Nov. 9, 2009 Financial-Services Bull: Barron’s talks with Anton Schutz, portfolio manager at the Burnham Financial Industries Fund (BURFX)...
By Jonas Elmerraji Posted on Nov. 9, 2009 Last week brought investors a welcome return to gains as the S&P 500 pushed up 3.2% over the course of the last five trading d...
By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...
A. maybe you should send a scout out ahead
of the trip first, have em scout out a
few of the places you see pictured in
the background of stockpickr
video's....since people usually hangout
with people of same background, in this
case....people who play with money.
while your scout is there have em scope
out the nasdaq building since the tv
shows (during fastmoney) that it's on
the groundfloor where the public can
look into the window.
though 3 of your choices, makes me
wonder about your intensions case.
A. The only one I own : SLX,
too hard pick a winner out all of them
Here are some of the biggest stocks that made the 52-week high list on Nov. 2, 2009. more
Here is a list of some of the biggest stocks that hit 52-week lows on Nov. 2, 2009. more
Analyst Downgrades for Nov. 2, 2009. Read more here. more













Comments not available